✦ LIBER ✦

PCV109 THERAPY INTERRUPTIONS IN PATIENTS SWITCHED FROM BRANDED TO OTHER GENERIC STATINS

✍ Scribed by RH Chapman; JS Benner; P Girase; M Benigno; KJ Axelsen; L Liu; MB Nichol

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV46 SWITCHING PATIENTS TO ROSUVASTATIN

✍ M James; J Brown; H Schuster 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Quantification and Description of Gastro

✍ Alexandra, Papaioannou; Ioannidis, George; Grima, Daniel; Adachi, Jonathan D. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Switching from branded alendronate or ri

✍ V. Ziller; K. Schüssel; S. Czeche; A. Franzmann; D. Klöckner; R. Quinzler; M. Sc 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 65 KB

PCV63 ECONOMIC IMPACT OF SWITCHING FROM

✍ J Signorovitch; J Zhang; EQ Wu; D Latremouille-Viau; AP Yu; H Dastani; KH Kahler 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

SAFETY AND EFFICACY CONCERNS IN SWITCHIN

✍ Kaplan, Steven A; Chung, Doreen E; Sandhu, Jaspreet S; Te, Alexis E 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB

PCV22 AN EVALUATION OF THE CLINICAL AND

✍ MA Omar; J Wilson 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB